Read the latest positive news, breakthroughs, and inspiring stories about multiple sclerosis, curated daily by BrightWire.
Emmy-winning actor Christina Applegate discovered she doesn't have MS after years of advocacy, sparking important awareness about diagnostic accuracy. Her honest response to the confusing news shows how medical mysteries can still lead to answers and hope.
A Liverpool father living with multiple sclerosis just shattered a world record by running a half marathon in 1 hour, 30 minutes, and 30 seconds. David Price's achievement shows others with MS that ambitious goals are still within reach.
A new adaptive trial design is testing multiple progressive MS treatments simultaneously, with early results showing one promising therapy will advance while another stops—proving the approach works. Australian patients can now join this faster, smarter way to find treatments.
Scientists at the University of Manitoba discovered a protein that could reverse multiple sclerosis damage, offering hope to 90,000 Canadians living with the incurable disease. Animal studies show the treatment can repair brain cells and restore mobility.
Researchers used one injection to reprogram immune cells inside the body, easing multiple sclerosis symptoms for at least six months. The breakthrough could make lifesaving therapy faster, cheaper, and available to millions more patients.
People newly diagnosed with multiple sclerosis who started B-cell therapy early had 62% fewer relapses than those on standard oral treatments. This breakthrough study gives doctors and patients clearer guidance on which treatments work best right from the start.
Sixteen people with multiple sclerosis saw their symptoms improve after receiving a groundbreaking treatment that produces disease-fighting immune cells directly inside their bodies. The therapy offers a faster, cheaper alternative to existing treatments.
An experimental pill for multiple sclerosis outperformed an approved drug in two major trials, giving 2,000 patients new hope for fewer relapses. The developer plans to seek global approval for the treatment.
A new multiple sclerosis treatment from Novartis has achieved positive results in clinical trials, offering fresh hope to millions living with this challenging autoimmune disease. The BTK inhibitor represents a promising advance in MS care.
Researchers have finally cracked the code on how Epstein-Barr virus leads to multiple sclerosis, opening the door to better treatments for the 2.9 million people living with the disease worldwide. The breakthrough also reveals why existing immunotherapy drugs work so well at slowing the condition.
A new real-world study shows the MS therapy Kesimpta keeps disease stable in over 90% of patients, especially when started early. The findings support using high-effectiveness treatments sooner rather than waiting for the disease to progress.
Multiple sclerosis patients switched from powerful medications to gentler oral treatments while staying healthy and cutting infection rates in half. The findings offer hope for personalized care that balances disease control with quality of life.